Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study | PLOS Medicine
Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study - International Journal of Infectious Diseases
TropicalMed | Free Full-Text | Missing Cases of Bacteriologically Confirmed TB/DR-TB from the National Treatment Registers in West and North Sumatra Provinces, Indonesia
MRIGlobal - As a partner in the Mycobacterium tuberculosis (Mtb) Quality Assessment Program (TBQA), we evaluate technologies, support research, and study trends that support improved response and treatment. Read more in our
Funding Opportunities | Vanderbilt Tuberculosis Center
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study | BMC Infectious Diseases | Full Text
Estimated viable Mtb in sputum during the first 56 days of treatment... | Download Scientific Diagram
Assay Procedure for the MTB/RIF Test. Two volumes of sample treatment... | Download Scientific Diagram
Integration of TB-LAM and Xpert MTB/RIF (Xpert) testing to improve TB case detection and shorten time to treatment initiation among People Living with HIV (PLHIV) in Harare City, Zimbabwe
Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine
Weakening Tuberculosis Bacteria's Defenses May Speed Treatment and Thwart Drug Resistance | Newsroom | Weill Cornell Medicine
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments | Science Advances
Early tuberculosis treatment monitoring by Xpert® MTB/RIF | European Respiratory Society
Figure 5 - Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia - Volume 22, Number 3—March 2016 - Emerging Infectious Diseases journal - CDC
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
Frontiers | Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019 | SpringerLink
Tuberculosis: Past, present and future of the treatment and drug discovery research - ScienceDirect
4.2 Adult and adolescent algorithms | MSF Medical Guidelines
Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis – TB DIAH
